Deepak Nitrite Limited CC-Dec23.pdf · 2024-02-15
So, I have two questions. So, one on the standalone, and then on the Phenolics. Sir, if you can share for Q3 and 9M FY24 what sort of volume growth we have witnessed in the standalone business. And along with if you can just share your thoughts on how much of our current capacity like including those debottleneck is currently utilized and has a scope for further utilization?
Sir, let’s say if we consider the backward integration projects what you mentioned, the nitric acid part. And coupled with the headroom of the capacities available with us in terms of the debottleneck and some pockets where it is currently underutilized. What's a fair assessment in terms of our quarterly EBITDA again moving to those ranges of Rs. 150 crores, which we used to do on a quarterly basis in FY23, because this quarter if we see we were at Rs. 112 crores. So, if you can just help us like what will be the combination of volume growth, as well as the benefits of backward integration facilities can help us to take that level of run rate in which of the quarters of FY25.